文献速递神经肌肉病

生活方式与肌萎缩侧索硬化症的关联:基于C9orf72基因分层的纵向人群病例对照研究

Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study.
PubMed 文献 · Lancet Neurol · 2021-01-01

这项纵向人群病例对照研究纳入143例C9orf72突变患者、1322例无突变患者和1322名对照,发现症状前数十年的生活方式差异与ALS风险相关且依赖C9orf72状态;工具变量分析支持吸烟和饮酒在无突变组中的因果效应。

要点

  • C9orf72突变与否影响症状前生活方式与ALS风险的关联模式。
  • 无突变组吸烟和饮酒的因果效应后验概率较高。
  • 年轻时期较高BMI可能增加无突变组ALS风险。

核心结论

  • ALS患者症状前数十年的生活方式与对照不同,且差异取决于C9orf72状态,可能参与症状前因果级联。

研究设计与样本

  • 纵向人群病例对照研究,纳入C9+组143例、C9-组1322例和年龄性别匹配的对照1322名。

主要发现

  • 与对照相比,C9+组和C9-组的吸烟包年数及症状起病时每日能量摄入更高,当前BMI和终生饮酒量更低。
  • 症状前中位BMI在C9+组低于对照,在C9-组高于对照;体力活动在C9+组与对照相似,在C9-组高于对照。
  • 纵向分析显示C9-组吸烟包年数从起病前47年开始更多,C9+组从24年前开始更多。

临床怎么用

  • 对于C9orf72突变携带者及ALS高危人群,应关注吸烟、饮酒和体重变化等可干预生活方式因素。
  • 生活方式干预可能有助于降低神经退行性疾病风险,但需结合基因状态个体化评估。

局限性

  • 研究为观察性设计,工具变量分析虽支持因果但无法完全排除残余混杂。
  • 生活方式数据依赖问卷回忆,可能存在测量误差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is considered to be caused by both genetic and environmental factors. The causal cascade is, however, not known. We aimed to assess lifestyle during the presymptomatic phase of ALS, stratified by C9orf72 mutation, and examine evidence supporting causality of lifestyle factors. METHODS: This study was a longitudinal, population-based, case-control study that used data from the Prospective ALS study the Netherlands. We included patients with a C9orf72 mutation (C9+ group), patients without a C9orf72 mutation (C9- group), and controls. Patients fulfilled the revised El Escorial criteria and were recruited through neurologists and rehabilitation physicians in the Netherlands as well as the Dutch Neuromuscular Patient Association and ALS Centrum website. 1322 population-based controls, matched for age and sex, were enrolled via the patients' general practitioners. Blood relatives or spouses of patients were not eligible as controls. We studied the relationship between ALS risk and smoking, alcohol, physical activity, body-mass index (BMI), and energy intake by the use of structured questionnaires. Smoking, physical activity, and BMI were longitudinally assessed up to 50 years before onset (defined as the period before onset of muscle weakness or bulbar symptoms for cases, or age at completing the questionnaire for controls). We calculated posterior probabilities (P(θ|x)) for causal effects of smoking, alcohol, and BMI, using Bayesian instrumental variable analyses. FINDINGS: Between Jan 1, 2006 and Jan 27, 2016, we included 143 patients in the C9+ group, 1322 patients in the C9- group, and 1322 controls. Compared with controls, cigarette pack-years (C9+ group mean difference from control 3·15, 95% CI 0·36 to 5·93, p=0·027; C9- group 3·20, 2·02 to 4·39, p<0·0001) and daily energy intake at symptom onset (C9+ group 712 kJ, 95% CI 212 to 1213, p=0·0053; C9- group 497, 295 to 700, p<0·0001) were higher in the C9+ and C9- groups, whereas current BMI (C9+ group -2·01 kg/m2, 95% CI -2·73 to -1·29, p<0·0001; C9- group -1·35, -1·64 to -1·06, p<0·0001) and lifetime alcohol consumption (C9+ group -5388 units, 95% CI -9113 to -1663, p=0·0046; C9- group -2185, -3748 to -622, p=0·0062) were lower in the C9+ and C9- groups. Median BMI during the presymptomatic phase for the C9+ group was lower (-0·69 kg/m2, 95% CI -1·24 to -0·13, p=0·015) and physical activity was similar (-348 metabolic equivalent of task [MET], 95% CI -966 to 270, p=0·27) to controls, whereas both the median BMI during the presymptomatic phase (0·27 kg/m2, 95% CI 0·04 to 0·50, p=0·022) and physical activity (585 MET, 291 to 878, p=0·0001) were higher in the C9- group than controls. Longitudinal analyses showed more cigarette pack-years in the C9- (starting 47 years pre-onset) and C9+ (starting 24 years pre-onset) groups, and higher physical activity over time in the C9- group (starting >30 years pre-onset). BMI of the C9+ group increased more slowly and was significantly lower (starting at 36 years pre-onset) than in controls, whereas the BMI of the C9- group was higher than controls (23-49 years pre-onset, becoming lower 10 years pre-onset). Instrumental variable analyses supported causal effects of alcohol consumption (P(θ|x)=0·9347) and smoking (P(θ|x)=0·9859) on ALS in the C9- group. We found evidence supporting a causal effect of increased BMI at younger age (mean 33·8 years, SD 11·7) in the C9- group (P[θ|x]=0·9272), but not at older ages. INTERPRETATION: Lifestyle during the presymptomatic phase differs between patients with ALS and controls decades before onset, depends on C9- status, and is probably part of the presymptomatic causal cascade. Identification of modifiable disease-causing lifestyle factors offers opportunities to lower risk of developing neurodegenerative disease. FUNDING: Netherlands ALS Foundation.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Westeneng HJ, van Veenhuijzen K, van der Spek RA, et al. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study. Lancet Neurol. 2021. PMID: 33894192. doi:10.1016/S1474-4422(21)00042-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。